Cloning & Mutagenesis Market to be dominated by Gene Induced Immunotherapy type through 2028
Increasing prevalence of chronic and genetic diseases is expected to drive the growth of global cloning & mutagenesis in the forecast period, 2024-2028. According to TechSci Research report, “ Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F ”, the global cloning & mutagenesis market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing prevalence of chronic and genetic diseases like cancer and HIV, along with growing healthcare expenditure across the globe. Additionally, growing investment on research and development for the treatment of genetic disorders and other diseases, especially in the developed countries in the North America and Europe, is expected to create lucrative opportunities for the market growth in the coming years. Besides, increasing demand for laboratory automation and more awareness of preventive healthcare is further ex...